Although cumulative cure rate, change of infected area and patient satisfaction are not standard evaluation methods for onychomycosis therapy, we could suggest a positive trend of treatment response.
← all excerpts
Randomized Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy with Short-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminium Garnet Laser and Amorolfine Nail Lacquer for Onychomycosis.
3
—
—
The sentences
In our clinical trial, using changes in lesion-free area as the primary endpoint showed borderline significance.
Using cure rate as a key secondary endpoint showed highly significant results in the test group compared to the control group.